NCT05638893View on ClinicalTrials.gov

Metformin as Adjuvant Therapy in Obese Knee Osteoarthritis Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

March 12, 2022

Study Completion Date

April 15, 2022

Conditions
Knee Osteoarthritis
Interventions
DRUG

Placebo Tablet

Placebo (tablet/12hr) + celecoxib (200mg/day) for three months.

DRUG

Metformin Hcl 500Mg Tab

Metformin (500mg/12hr) + celecoxib (200mg/day) for three months.

Trial Locations (1)

31527

Tanta university, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT05638893 - Metformin as Adjuvant Therapy in Obese Knee Osteoarthritis Patients | Biotech Hunter | Biotech Hunter